On July 18, 2024, High-Flyer Quant deployed 153 of its private placement products to subscribe to the IPO of ChangXin Memory Technologies (CXMT). The event made headlines for its scale—153 funds targeting a single company—but the real story lies beneath the surface: the intersection of capital, geopolitics, and technology gaps.
I have spent the last decade auditing smart contracts and risk structures, from the 2017 ICO due diligence to the 2020 DeFi stability assessments. The pattern is always the same. When a narrative-driven asset exceeds its fundamental justification by an order of magnitude, the market is not betting on technology. It is betting on narrative protection. The CXMT IPO is no different.
Context: CXMT is China’s only DRAM manufacturer with a 17nm DDR5 process. It holds approximately 3-5% of the global DRAM market, trailing Samsung, SK Hynix, and Micron. Its IPO pricing was set at 8.78 RMB per share, implying a market cap between 2 and 5 trillion RMB. That is not a typo. For perspective, Samsung’s DRAM division—which commands 42% of the global market—has an implied valuation of under 1 trillion RMB when isolated. The Chinese premium is real.
Core Analysis: Let me walk through the technical and financial data that the market is ignoring.
Yield Gap: CXMT’s 17nm yields are estimated at 60-70%. Industry benchmarks for comparable nodes are 85-90%. That single gap translates to a 30-40% cost disadvantage. DRAM is a commodity. A 30% cost handicap in a market where margins are already thin is not a competitive position. It is a subsidy-dependent survival strategy.
Equipment Dependency: Over 90% of CXMT’s lithography equipment is imported from ASML and Nikon. The advanced immersion DUV tools required for 1β node are under export license control. CXMT has stockpiled equipment before the 2022 US export restrictions, but stockpiles are finite. Maintenance and replacement parts remain vulnerable. The US could add CXMT to the Entity List at any time—a move that would freeze equipment service and collapse wafer output within months.
HBM Absence: High Bandwidth Memory (HBM) is the fastest-growing segment in DRAM, driven entirely by AI training. HBM will represent 30% of total DRAM revenue by 2025. CXMT has no HBM product. It is not even on the publicly available roadmap. The company is betting its entire future on a technology wave that is left in the harbor.
Financial Valuation: The IPO PE ratio at 8.78 RMB is 50-60x forward earnings, assuming 40 billion RMB net profit in 2024. Samsung’s DRAM PE is 15x. SK Hynix trades at 10x. To justify a 50x multiple, CXMT would need to grow earnings at 40% CAGR for a decade—while closing a 1.5-node technology gap, surviving equipment restrictions, and entering a market (HBM) where it currently has zero competence. That is not analysis. That is hope.
High-Flyer’s Position: 153 funds is not a coincidence. Structurally, these funds appear as separate legal entities, but the subscription behavior suggests they are shell channels for a single beneficial owner. This is reminiscent of the 2017 ICO structures I audited in Vietnam, where multiple wallets were used to bypass cap limits. The regulatory risk is real. The Shanghai Stock Exchange’s IPO review will likely question whether these funds violate the 10% subscription cap for related parties. If the structure is deemed a compliance violation, the IPO could be suspended.
Contrarian Angle: The market narrative frames CXMT as a “national champion” and High-Flyer as a “smart money” endorsing the technology. My contrarian view is the opposite. High-Flyer is not betting on CXMT’s technology. It is betting on the Chinese government’s willingness to subsidize the stock through state-backed funds and policy support. In a bear market for crypto, but a bull market for semiconductor narratives, the real risk is not that CXMT fails—it is that the IPO is a capital trap that locks institutional investors into a low-liquidity, high-volatility asset.
Furthermore, the 8.78 RMB pricing was engineered through reverse DCF modeling with assumptions that are not just optimistic but detached from physical reality. The model assumes CXMT reaches 15% global market share by 2030. To achieve that, it would need to triple its wafer output and match Samsung’s yield—both of which require uninterrupted access to equipment that is currently restricted. The DCF is not a forecast. It is a fictional narrative that the market is being asked to buy.
Takeaway: The CXMT IPO is a signal for systemic risk in the Chinese semiconductor capital market. It is not fundamentally different from the ICO bubble or the DeFi oracle failures I analyzed in 2020. The underlying technology is real—17nm DDR5 is a legitimate achievement—but the valuation is divorced from the physical constraints. High-Flyer’s 153 funds is not a vote of confidence. It is a capital structure designed to exploit a regulatory gap. The question is not whether the stock will rise on day one. It is whether the market has the discipline to audit the logic instead of the narrative.
